6
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Effect of Lazaroid U-74389G on Pulmonary Ischemia - Reperfusion Injury in Dogs

, , , , , , , & show all
Pages 83-92 | Published online: 09 Jul 2009

References

  • Sundaresan S, Alevy YG, Steward N, Tucker J, Trulock EP, Cooper JD, Patterson GA, Mohanakuma r T. Cytokine gene transcripts for tumor necrosis factor-®, interleukin-2, and interferon-° in human pulmonary allografts. J Heart Lung Transplant. 1995;14:512 –518.
  • Cooper JD. Lung transplantation: A new era. Ann Thorac Surg. 1987;44:447 –448.
  • Keenan RJ, Griffth BP, Kormos RL, Armitage JM, Hardesty RL. Increased peri-operative lung preservation injury with lung procurement by Euro-Collins solution fush. J Heart Lung Transplant. 1991;10:650 –655.
  • Paull DE, Keagy BA, Kron EJ, Wilcox BR. Reperfusion injury in the lung preserved for 24 hours. Ann Thorac Surg. 1989;47:187 –192.
  • Todo S, Hamada N, Zhu Y, Zhang S, Subbotin V, Nemoto A, Takeyoshi I, Starzl TE. Lazaroid U-74389G for 48-hour canine liver preservation. Transplantation. 1996;61:189– 194.
  • Hall ED, Pazara KE, Braughler JM. 21-aminosteroid lipid peroxidation inhibitor U74006F protects against cerebral ischemia in gerbils. Stroke. 1988;19:997 –1002.
  • Park CK, Hall ED. Dose-response analysis of the effect of 21-aminosteroid tirilazad mesylate (U-74006F) upon neurological outcome and ischemic brain damage in per- manent focal cerebral ischemia. Brain Res. 1994;645:157–163.
  • Aeba R, Killinger WA, Keenan RJ, Yousem SA, Hamamoto I, Hardesty RL, Griffth BP. Lazaroid U74500A as an additive to University of Wisconsin solution for pul- monary grafts in the rat transplant model. J Thorac Car- diovasc Surg. 1992;104:1333 –1339.
  • Cosenza CA, Cramer DV, Cunneen SA, Tuso PJ, Wang HK, Makowka L. Protective effect of the lazaroid U74006F in cold ischemia-reperfusion injury of the liver. Hepatology. 1994;19:418–425.
  • Hendry PJ, Anstadt MP, Plunkett MD, Amato MT, Menius JA Jr, Lowe JE. Improved donor myocardial recov- ery with a new lazaroid lipid antiperoxidant in the isolated canine heart. J Heart Lung Transplant. 1992;11:636 –645.
  • Thomas DD, Sharar SR, Winn RK, Chi EY, Verrier ED, Allen MD, Bishop MJ. CD18-independen t mechanism of neutrophil emigration in the rabbit lung after ischemia–reperfusion. Ann Thorac Surg. 1995;60:1360– 1366.
  • Chen CZ, Gallagher RC, Ardery P, Dyckman W, Low HB. Retrograde versus antegrade fush in canine left lung preservation for six hours. J Heart Lung Transplant. 1996;15:395–403.
  • Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate–phenol – chloroform extraction. Anal Biochem. 1987;162:156– 159.
  • Braughler JM, Pregenzer JF, Chase RL, Duncan LA, Jacobsen EJ, McCall JM. Novel 21-amino steroids as potent inhibitors of iron-dependen t lipid peroxidation. J Biol Chem. 1987;262:10438 –10440.
  • Hall ED, Yonkers PA. Attenuation of postischemic cerebral hypoperfusion by the 21-aminosteroid U74006F. Stroke. 1988;19:340 –344.
  • Killinger WA Jr, Dorof DB, Keagy BA, Johnson G Jr. Im- provement of endothelial cell viability at 4 degrees C by addition of lazaroid U74500A to preservation solutions. Transplantation. 1992;53:983 –986.
  • Braughler JM, Hall ED, Jacobsen EJ, McCall JM, Means ED. The 21-aminosteroids: Potent inhibitors of lipid peroxida- tion for the treatment of central nervous system trauma and ischemia. Drug Future. 1989;14:143–152.
  • Haynes J Jr, Seibert A, Bass JB, Taylor AE. U74500A in- hibition of oxidant-mediated lung injury. Am J Physiol. 1990;259:H144–148.
  • Shenkar R, Abraham E. Effects of treatment with the 21-aminosteroid, U74389F, on pulmonary cytokine expression following hemorrhage and resuscitation. Crit Care Med. 1995;23:132 –139.
  • Adoumie R, Serrick C, Giaid A, Shennib H. Early cel- lular events in the lung allograft. Ann Thorac Surg. 1992;54:1071 –1077.
  • Johnson J, Meyrick B, Jesmok G, Brigham KL. Human recombinant tumor necrosis factor alpha infusion mim- ics endotoxemia in awake sheep. J Appl Physiol. 1989; 66:1448–1454.
  • Seekamp A, Warren JS, Remick DG, Till GO, Ward PA. Requirements for tumor necrosis factor-® and interleukin- 1 in limb ischemia/reperfusion injury and associated lung injury. Am J Pathol. 1993;143:453 –463.
  • Serrick C, Adoumie R, Giaid A, Shennib H. The early release of interleukin-2, tumor necrosis factor-® and interferon-° after ischemia reperfusion injury in the lung allograft. Transplantation. 1994;58:1158 –1162.
  • Sternbergh WC III, Tuttle TM, Makhoul RG, Bear HD, Sobel M, Fowler AA III. Postischemic extremities exhibit immediate release of tumor necrosis factor. J Vasc Surg. 1994;20:474 –481.
  • Welbour n R, Goldman G, O’Riordain M, Lindsay TF, Paterson IS, Kobzik L, Valeri CR, Shepro D, Hechtman HB. Role for tumor necrosis factor as mediator of lung injury following lower torso ischemia. J Appl Physiol. 1991;70:2645 –2649.
  • Colletti LM, Remick DG, Burtch GD, Kunkel SL, Strieter RM, Campbell DA Jr. Role of tumor necrosis factor- ® in the pathophysiologic alterations after hepatic is- chemia/reperfusion injury in the rat. J Clin Invest. 1990; 85:1936–1943.
  • Caty MG, Guice KS, Oldham KT, Remick DG, Kunkel SI. Evidence for tumor necrosis factor-induced pulmonary mi- crovascular injury after intestinal ischemia–reperfusion in- jury. Ann Surg. 1990;212:694 –700.
  • Palace GP, Del Vecchio PJ, Horgan MJ, Malik AB. Re- lease of tumor necrosis factor after pulmonary artery occlusion and reperfusion. Am Rev Respir Dis. 1993; 147:143–147.
  • Chang D, Hsu K, Ding Y Chiang C. Interleukin-1 in ischemia-reperfusion acute lung injury. Am J Respir Crit Care Med. 1997;156:1230 –1234.
  • Kamoshita N, Takeyoshi I, Ohwada S, Iino Y, Mor- ishita Y. The effect of FR167653 on pulmonary ischemia– reperfusion injury in dogs. J Heart Lung Transplant. 1997;16:1062 –1072.
  • Matsumura A, Nakahara K, Miyoshi S, Mizuta T, Akashi A, Kawashima Y. Filtration coeffcient in isolated preserved and reperfused canine lung. J. Surg Res. 1991;50:205– 211.
  • Fleishaker JC, Peters GR, Cathcart KS. Evaluation of the pharmacokinetics and tolerability of tirilazad mesy- late, a 21-aminosteroid free radical scavenger; I: Sin- gle dose administration. J Clin Pharmacol. 1993;33:175– 181.
  • Johnson J, Brigham KL, Jesmok G, Meyrick B. Morphologic changes in lungs of anesthetized sheep following intra- venous infusion of recombinant tumor necrosis factor ®. Am Rev Respir Dis. 1991;144:179 –186.
  • Stephens KE, Ishizaka A, Larrick JW, Raffn TA. Tumor necrosis factor causes increased pulmonary permeabil- ity and edema. Am Rev Respir Dis. 1988;137:1364– 1370.
  • Ohwada S, Tomizawa N, Takahashi T, Ichikawa H, Kamoshita N, Kobayashi J, Ohya T, Ogawa T, Izumi M, Nakamur a S, Iino Y, Morishita Y. Effects of a specifc neu- trophil elastase inhibitor (ONO-5046 Na) and neutrophil depletion using a G-1 column on lung reperfusion injury in dogs. Transplant Proc. 1996;28:1826–1827.
  • Yamashita C, Oobo H, Tsuji F, Tobe S, Yamamoto H, Nakamur a H, Okada M, Nakamur a K. Effect of prostaglandin I2 and superoxide dismutase on reperfu- sion injury of warm ischemic lung. Ann Thorac Surg. 1992;54:921 –924.
  • Moore TM, Khimenko PL, Taylor AE. Endothelial damage caused by ischemia and reperfusion and different ventila- tory strategies in the lung. Clin J Physiol. 1996;39:65–81.
  • Barbotin-Larrieu F, Mazmanian M, Baudet B, Detruit H, Chapelier A, Libert JM, Dartevelle P, Herve P. Prevention of ischemia reperfusion lung injury by inhaled nitric oxide in neonatal piglets. J Appl Physiol. 1996;80:782–788.
  • Mazmanian GM, Baudet B, Brink C, Cerrina J, Kirkiacharian S, Weiss M. Methylene blue potentiates vascular reactivity in isolated rat lungs. J Appl Physiol. 1989;66:1040 –1045.
  • Seibert AF, Haynes J, Taylor AE. Ischemia–reperfusion in- jury in the isolated rat lung. Role of fow and endogenou s leukocytes. Am Rev Respir Dis. 1993;147:270 –275.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.